Corinna Cohn: Post-Trans No Man's Land
At 19 I was promised a ‘normal female body.’ 30 years of estrogen and a vaginoplasty later, I’m a medically feminized male with no sexual pleasure, daily pain, and lifelong hormone dependence. You can’t actually change sex—and you can’t undo it.
Общ преглед
Corinna Cohn, 47, recounts 30 years on estrogen and vaginoplasty at 19, now living in what he calls a “post-trans no-man’s-land”: a medically feminized male facing lifelong hormone dependence, loss of sexual pleasure, daily dilation pain, and irreversible bodily changes. He rejects the “detransitioner” label as misleading, calls for rigorous informed-consent standards, and warns that regret is real and irreversible.
Пълно обобщение на видеото
Corinna Cohn, co-host of the “heterodorks” podcast and author of the 2022 Washington Post op-ed “What I wish I’d known when I was 19 and had sex-reassignment surgery,” tells host Stephanie Winn that after nearly three decades on estrogen and having undergone vaginoplasty at 19, he now lives in what he calls a “post-trans no-man’s-land.” Now 47, Cohn describes himself as “a male who has been medically feminized,” emphasizing that “you can’t actually change sex.” He explains that 30 years of exogenous estrogen have permanently altered his body; switching to testosterone would only add male-pattern hair growth without reversing breast development or other feminized traits, leaving him physically “a different person than most men.” Because his testes were removed, he must remain on some form of hormone replacement for life, so the popular injunction to “just detransition” is, in his words, “infuriating” and biologically naïve. Cohn is frank about the physical and sexual costs: partnered sex is no longer pleasurable, masturbation yields only “a puff of a sneeze of a sensation,” and he lives with ongoing medical complications he “never would have signed up for.” He challenges the narrative that neo-vaginas are functionally equivalent, noting the need for painful daily dilation and far less elasticity than natal vaginal tissue, and he dismisses claims that gynecologists cannot tell the difference as “a load of crap.” Reviewing the language used for people like him, he finds “detransitioner” useful as shorthand but misleading because so much is irreversible; he prefers “survivor of gender medicine,” stressing that some do not survive—citing elevated suicide rates and lethal surgical complications. Asked how the gender-affirming industry became a “billion-dollar machine,” Cohn argues that trans people themselves serve as its most effective marketers: “We brag about the procedures… and push one another to have more work done,” while any expression of regret is framed as a threat to the community’s access to care. He recalls his own teenage belief that surgery would give him a “normal body” and seamless social integration as a woman, an expectation he now calls “wholly inaccurate.” Although strangers were often convinced, he never persuaded himself: “There is a lot of yearning and a lot of pain inside of even people who say that they’re happier that they transitioned.” He therefore rejects the idea of “true trans,” attributing gender distress more to cultural intolerance of sex-atypical behavior than to in-utero destiny. Despite disillusionment, Cohn says he has found meaning in small, embodied pleasures—morning coffee, autumn light, the simple ability to run across a tennis court—and urges others to “avail myself of the wonders of the universe” without tethering identity to gender labels. He advocates for adult access to transition-related procedures only under rigorous informed-consent standards, full disclosure of risks (medical and social), and an end to taxpayer funding in the absence of robust long-term evidence. Until such safeguards exist, he views the current system as failing both children and adults, leaving people like him to navigate lifelong consequences that no further surgery can undo.